# Aspira Women's Health Inc. (AWH) Source: https://www.quantisnow.com/company/AWH Generated: 2026-11-12T04:50:08.792Z - Ticker: AWH - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances - Website: aspirawh.com ## About Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer. The company has a strategic alliance with Quest Diagnostics, Incorporated. It serves physician office and hospital laboratories, as well as physicians. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. ## Latest AWH news and filings - 2026-05-26 13:02 UTC [Market Insight] [Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health](https://www.quantisnow.com/insight/aspira-womens-health-and-cleveland-clinic-expand-strategic-collaboration-to-6571578) - 2026-04-23 12:55 UTC [Market Insight] [Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)](https://www.quantisnow.com/insight/aspira-womens-health-otcqbawhl-enters-key-growth-phase-with-molecular-6511890) - 2025-11-14 12:35 UTC [Market Insight] [Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/aspira-announces-third-quarter-2025-financial-results-and-provides-business-6279008) - 2025-10-29 11:00 UTC [Market Insight] [Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston](https://www.quantisnow.com/insight/aspira-womens-health-wins-laboratory-service-contract-with-university-of-6248879) - 2025-09-18 11:00 UTC [Market Insight] [Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise](https://www.quantisnow.com/insight/aspira-womens-health-announces-equity-capital-infusion-of-306-million-6204902) - 2025-09-04 11:00 UTC [Market Insight] [Aspira Women's Health Appoints New Chief Financial Officer](https://www.quantisnow.com/insight/aspira-womens-health-appoints-new-chief-financial-officer-6189171) - 2025-08-13 10:00 UTC [Market Insight] [Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/aspira-announces-second-quarter-2025-financial-results-and-provides-business-6161769) - 2025-07-15 20:01 UTC [Market Insight] [Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors](https://www.quantisnow.com/insight/aspira-womens-health-announces-appointment-of-jane-pine-wood-to-6120525) - 2025-06-17 11:00 UTC [Market Insight] [Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients](https://www.quantisnow.com/insight/aspira-womens-health-partners-with-dorsata-to-offer-access-to-6089089) - 2025-06-11 12:30 UTC [Market Insight] [Aspira Women's Health Provides Update on ARPA-H Sprint Program Partnership to Advance Women's Health](https://www.quantisnow.com/insight/aspira-womens-health-provides-update-on-arpa-h-sprint-program-partnership-6081586) - 2025-05-19 11:55 UTC [Market Insight] [Aspira Announces First Quarter 2025 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/aspira-announces-first-quarter-2025-financial-results-and-provides-business-6046810) - 2025-05-07 11:00 UTC [Market Insight] [Aspira Successfully Completes Application to the OTCQB](https://www.quantisnow.com/insight/aspira-successfully-completes-application-to-the-otcqb-6022591) - 2025-05-01 11:00 UTC [Market Insight] [Aspira Reaches Another ARPA-H Milestone, Eligible to Receive Additional $1.5 Million in Second Quarter](https://www.quantisnow.com/insight/aspira-reaches-another-arpa-h-milestone-eligible-to-receive-additional-15-6011958) - 2025-05-01 00:10 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-aspira-womens-health-inc-6011644) - 2025-04-28 23:19 UTC [SEC Form 3] [New insider Fraser John D claimed ownership of 841,558 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-fraser-john-d-claimed-ownership-of-841558-shares-6005514) - 2025-04-25 01:41 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hundorfean Cynthia D](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hundorfean-cynthia-d-6001465) - 2025-04-22 20:05 UTC [SEC Form DEFR14A filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/sec-form-defr14a-filed-by-aspira-womens-health-inc-5996376) - 2025-04-17 10:00 UTC [Market Insight] [Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"](https://www.quantisnow.com/insight/aspira-womens-health-inc-to-begin-trading-april-17th-on-5990939) - 2025-04-16 21:07 UTC [SEC Form 8-K] [Aspira Women's Health Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/aspira-womens-health-inc-filed-sec-form-8-k-financial-statements-5990580) - 2025-04-16 20:00 UTC [Market Insight] [Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq](https://www.quantisnow.com/insight/aspira-womens-health-inc-announces-receipt-of-delisting-notification-from-5990027) - 2025-04-15 23:48 UTC [SEC Form S-1] [SEC Form S-1 filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-aspira-womens-health-inc-5989228) - 2025-04-11 21:29 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-aspira-womens-health-inc-5985828) - 2025-04-08 12:30 UTC [SEC Form 8-K] [Aspira Women's Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/aspira-womens-health-inc-filed-sec-form-8-k-entry-into-5980730) - 2025-04-08 11:00 UTC [Market Insight] [Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement](https://www.quantisnow.com/insight/aspira-appoints-three-new-directors-executes-20-million-equity-purchase-5980512) - 2025-04-02 12:23 UTC [SEC Form 4] [Director Vos Ellen O'Connor converted options into 5,313 shares, increasing direct ownership by 8% to 68,677 units (SEC Form 4)](https://www.quantisnow.com/insight/director-vos-ellen-oconnor-converted-options-into-5313-shares-increasing-5971238) - 2025-04-02 01:01 UTC [SEC Form 4] [Director Parnell Winfred converted options into 5,156 shares, increasing direct ownership by 8% to 66,053 units (SEC Form 4)](https://www.quantisnow.com/insight/director-parnell-winfred-converted-options-into-5156-shares-increasing-direct-5970775) - 2025-04-02 00:59 UTC [SEC Form 4] [Director Beausang Ellen converted options into 1,615 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-beausang-ellen-converted-options-into-1615-shares-sec-form-5970760) - 2025-04-02 00:57 UTC [SEC Form 4] [SEC Form 4 filed by Director Beausang Ellen](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-beausang-ellen-5970759) - 2025-04-02 00:55 UTC [SEC Form 3] [SEC Form 3 filed by new insider Beausang Ellen](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-beausang-ellen-5970756) - 2025-04-01 22:42 UTC [SEC Form 4] [Director Ragard John Phillip converted options into 4,843 shares, increasing direct ownership by 4% to 129,890 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ragard-john-phillip-converted-options-into-4843-shares-increasing-5970580) - 2025-04-01 22:42 UTC [SEC Form 4] [Director Cavanaugh Stefanie L. converted options into 5,938 shares, increasing direct ownership by 9% to 72,789 units (SEC Form 4)](https://www.quantisnow.com/insight/director-cavanaugh-stefanie-l-converted-options-into-5938-shares-increasing-5970578) - 2025-04-01 22:42 UTC [SEC Form 4] [Director Fralick Celeste Rachelle converted options into 5,000 shares, increasing direct ownership by 10% to 55,665 units (SEC Form 4)](https://www.quantisnow.com/insight/director-fralick-celeste-rachelle-converted-options-into-5000-shares-increasing-5970577) - 2025-04-01 22:42 UTC [SEC Form 4] [Director Herchuk Jannie Prestridge converted options into 8,438 shares, increasing direct ownership by 13% to 74,065 units (SEC Form 4)](https://www.quantisnow.com/insight/director-herchuk-jannie-prestridge-converted-options-into-8438-shares-increasing-5970576) - 2025-03-31 21:21 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-aspira-womens-health-inc-5967798) - 2025-03-31 20:05 UTC [SEC Form 8-K] [Aspira Women's Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/aspira-womens-health-inc-filed-sec-form-8-k-amendments-to-5966992) - 2025-03-31 20:05 UTC [SEC Form 8-K] [Aspira Women's Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/aspira-womens-health-inc-filed-sec-form-8-k-leadership-update-5966990) - 2025-03-31 12:00 UTC [Market Insight] [Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award](https://www.quantisnow.com/insight/aspira-receives-15-million-milestone-payment-from-the-arpa-h-sprint-5966152) - 2025-03-27 21:28 UTC [SEC Form 10-K] [SEC Form 10-K filed by Aspira Women's Health Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-aspira-womens-health-inc-5963724) - 2025-03-27 20:05 UTC [SEC Form 8-K] [Aspira Women's Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/aspira-womens-health-inc-filed-sec-form-8-k-results-of-5963017) - 2025-03-27 20:00 UTC [Market Insight] [Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results](https://www.quantisnow.com/insight/aspira-womens-health-reports-fourth-quarter-and-full-year-2024-5962906) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AWH - Earnings history: https://www.quantisnow.com/earnings/AWH - Dividend history: https://www.quantisnow.com/dividends/AWH - Insider transactions: https://www.quantisnow.com/insiders/AWH - Options chain: https://www.quantisnow.com/options/AWH - SEC 8-K filings only: https://www.quantisnow.com/company/AWH/8-k - RSS and alerts for AWH: https://www.quantisnow.com/docs/rss-feeds.md